Smart Money Group LLC Purchases New Position in UnitedHealth Group Incorporated (NYSE:UNH)

by · The Markets Daily

Smart Money Group LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 383 shares of the healthcare conglomerate’s stock, valued at approximately $200,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in UNH. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group during the fourth quarter valued at approximately $30,000. Finally, Promus Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth $32,000. 87.86% of the stock is currently owned by institutional investors.

Insider Activity

In other UnitedHealth Group news, CEO Stephen J. Hemsley bought 86,700 shares of the stock in a transaction on Friday, May 16th. The shares were bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer directly owned 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the business’s stock in a transaction on Wednesday, May 14th. The stock was acquired at an average price of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director owned 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have acquired 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently weighed in on UNH. UBS Group dropped their target price on UnitedHealth Group from $400.00 to $385.00 and set a “buy” rating on the stock in a research note on Wednesday, June 25th. Oppenheimer cut their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating on the stock in a report on Wednesday, May 14th. Raymond James Financial downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Mizuho lowered their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. Finally, Robert W. Baird downgraded UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 target price on the stock. in a research report on Wednesday, June 11th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $415.57.

Get Our Latest Report on UnitedHealth Group

UnitedHealth Group Stock Up 0.4%

UNH opened at $308.69 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market capitalization of $280.03 billion, a price-to-earnings ratio of 12.93, a PEG ratio of 1.46 and a beta of 0.45. The company has a fifty day moving average of $327.18 and a two-hundred day moving average of $448.90.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same quarter in the prior year, the company posted $6.91 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a $2.21 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.86%. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles